Latest News

The Nottingham site also supports Codis’ commercial spray-drying operations in Haverhill, U.K., where the company is increasing capacity by installing a new GEA Pharma-SD PSD-4 commercial spray dryer, with validation planned for 2027.

Researchers will use GE HealthCare’s StarGuide SPECT/CT imaging system together with MIM Software’s MIM LesionID Pro platform to monitor how tumours respond throughout treatment.

The EC signed the framework agreement after a request from six participating countries, including Austria, Denmark, Ireland, Luxembourg, Norway, and Portugal.

The minimally invasive procedure was carried out on a 44-year-old woman by Dr. A.B. Gopalamurugan, Structural Interventional Cardiologist at the hospital.

Under the agreement, Novo Nordisk will internally assess Vivani’s investigational NPM-139 implant, which utilizes the company’s proprietary NanoPortal technology to deliver semaglutide continuously over extended periods through a miniature subdermal device.

Unlike conventional open surgery, which requires large incisions in the chest and abdomen, MIE uses several small incisions, high-definition imaging, and specialized laparoscopic instruments.

Under the agreement, Everest Medicines will receive US$112.5 million upfront from Travere Therapeutics and could earn up to US$1.03 billion more in milestone payments if certain clinical, regulatory, and commercial goals are met across five indications.

The investment forms part of the hospital’s broader strategy to expand access to next-generation medical technologies despite Lebanon’s ongoing healthcare and economic challenges.

The new collaboration centres on CSPC’s small interfering RNA (siRNA) drug discovery platform and its proprietary delivery technology, which is designed to transport therapies beyond the liver.

Following the sale, Clarivate will concentrate on its Academia & Government (A&G) and Intellectual Property (IP) divisions.